{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T17:01:51Z","timestamp":1788454911817,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,6,2]],"date-time":"2018-06-02T00:00:00Z","timestamp":1527897600000},"content-version":"am","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100016730","name":"Torii","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100016730","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.jaci.2016.09.043","type":"journal-article","created":{"date-parts":[[2016,11,15]],"date-time":"2016-11-15T19:40:18Z","timestamp":1479238818000},"page":"1840-1848.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":110,"title":["Efficacy and safety of the SQ house dust mite sublingual immunotherapy tablet in Japanese adults and adolescents with house dust mite\u2013induced allergic rhinitis"],"prefix":"10.1016","volume":"139","author":[{"given":"Kimihiro","family":"Okubo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Masuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Imai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Okamiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian Sonne","family":"Stage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorthe","family":"Seitzberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiyoshi","family":"Konno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl","key":"10.1016\/j.jaci.2016.09.043_bib1","first-page":"1","article-title":"Allergen immunotherapy: therapeutic vaccines for allergic diseases. Geneva: January 27-29 1997","volume":"53","year":"1998","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2016.09.043_bib2","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s11882-002-0074-2","article-title":"Dust mite allergens: ecology and distribution","volume":"2","author":"Arlian","year":"2002","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaci.2016.09.043_bib3","first-page":"211","article-title":"Geography of house dust mite allergens","volume":"28","author":"Thomas","year":"2010","journal-title":"Asian Pac J Allergy Immunol"},{"key":"10.1016\/j.jaci.2016.09.043_bib4","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0091-6749(05)80006-5","article-title":"Prevalence of dust mites in homes of people with asthma living in eight different geographic areas of the United States","volume":"90","author":"Arlian","year":"1992","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.09.043_bib5","first-page":"226","article-title":"Domestic mite species and Der p 1 allergen levels in nine locations in Australia","volume":"12","author":"Tovey","year":"2000","journal-title":"ACI Int"},{"key":"10.1016\/j.jaci.2016.09.043_bib6","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.it.2011.06.006","article-title":"Orchestrating house dust mite-associated allergy in the lung","volume":"32","author":"Gregory","year":"2011","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jaci.2016.09.043_bib7","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/all.12796","article-title":"Patterns of IgE sensitization in house dust mite-allergic patients. Implications for allergen immunotherapy","volume":"71","author":"Batard","year":"2016","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2016.09.043_bib8","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2332\/allergolint.11-RAI-0334","article-title":"Japanese guideline for allergic rhinitis","volume":"60","author":"Okubo","year":"2011","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaci.2016.09.043_bib9","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000381059","article-title":"Efficacy and safety of sublingual immunotherapy for two seasons in patients with Japanese cedar pollinosis","volume":"166","author":"Okamoto","year":"2015","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2016.09.043_bib10","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1398-9995.2007.01451.x","article-title":"Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT trial","volume":"62","author":"Jacobsen","year":"2007","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2016.09.043_bib11","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S1081-1206(10)60211-6","article-title":"Preventive effects of sublingual immunotherapy in childhood: an open randomized controlled trial","volume":"101","author":"Marogna","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2016.09.043_bib12","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jaci.2011.12.973","article-title":"SQ-standardized sublingual grass immunotherapy: confirmation of disease modification 2 years after 3 years of treatment in a randomized trial","volume":"129","author":"Durham","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.09.043_bib13","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.jaci.2010.08.030","article-title":"Long-lasting effects of sublingual immunotherapy according to its duration: a 15-year prospective trial","volume":"126","author":"Marogna","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.09.043_bib14","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1046\/j.1365-2222.2001.01161.x","article-title":"Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A\u00a0six-year follow-up trial","volume":"31","author":"Pajno","year":"2001","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2016.09.043_bib15","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jaci.2015.06.036","article-title":"Effective treatment of house dust mite-induced allergic rhinitis with 2 doses of the SQ HDM SLIT-tablet: results from a randomized double-blind, placebo-controlled phase III trial","volume":"137","author":"Demoly","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.09.043_bib16","first-page":"154","article-title":"Tolerability during double-blind randomized phase I trials with the house dust mite allergy immunotherapy tablet in adults and children","volume":"24","author":"Corzo","year":"2014","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaci.2016.09.043_bib17","year":"1996"},{"key":"10.1016\/j.jaci.2016.09.043_bib18","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.alit.2015.01.005","article-title":"Japanese Society of allergology task force report on standardization of house dust mite allergen vaccines\u2014secondary publication","volume":"64","author":"Takai","year":"2015","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaci.2016.09.043_bib19","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000444016","article-title":"Fractionation of source materials leads to a high reproducibility of the SQ house dust mite SLIT-tablets","volume":"169","author":"Henmar","year":"2016","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2016.09.043_bib20","series-title":"Guideline on the clinical development of products for specific immunotherapy for the treatment of allergic diseases","year":"2008"},{"key":"10.1016\/j.jaci.2016.09.043_bib21","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.anai.2014.11.015","article-title":"SQ house dust mite sublingually administered immunotherapy tablet (ALK) improves allergic rhinitis in patients with house dust mite allergic asthma and rhinitis symptoms","volume":"114","author":"Mosbech","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2016.09.043_bib22","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/pst.210","article-title":"A note on the power of Fisher's least significant difference procedure","volume":"5","author":"Meier","year":"2006","journal-title":"Pharm Stat"},{"key":"10.1016\/j.jaci.2016.09.043_bib23","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.jaci.2013.11.012","article-title":"Efficacy and safety of sublingual tablets of house dust mite allergen extracts in adults with allergic rhinitis","volume":"133","author":"Bergmann","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.09.043_bib24","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/WOX.0b013e3181c6c379","article-title":"Sub-Lingual Immunotherapy World Allergy Organization Position Paper 2009","volume":"2","author":"Canonica","year":"2009","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jaci.2016.09.043_bib25","unstructured":"US Food and Drug Administration. Briefing document Oralair\u20142013 meeting materials, allergenic products advisory committee. 2013b. Available at: http:\/\/www.fda.gov\/downloads\/AdvisoryCommittees\/CommitteesMeetingMaterials\/BloodVaccinesandOtherBiologics\/AllergenicProductsAdvisoryCommittee\/UCM377852.pdf. Accessed February 15, 2016."},{"key":"10.1016\/j.jaci.2016.09.043_bib26","unstructured":"US Food and Drug Administration. Briefing document Ragwitek\u20142014 meeting materials, allergenic products advisory committee. 2014. Available at: http:\/\/www.fda.gov\/downloads\/AdvisoryCommittees\/CommitteesMeetingMaterials\/BloodVaccinesandOtherBiologics\/AllergenicProductsAdvisoryCommittee\/UCM382841.pdf. Accessed February 15, 2016."},{"key":"10.1016\/j.jaci.2016.09.043_bib27","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1398-9995.2003.00420.x","article-title":"Symptoms of persistent allergic rhinitis during a full calendar year in house dust mite-sensitive subjects","volume":"59","author":"Downie","year":"2004","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2016.09.043_bib28","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/j.jaci.2014.12.1911","article-title":"Onset and dose-related efficacy of house dust mite sublingual immunotherapy tablets in an environmental exposure chamber","volume":"135","author":"Nolte","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.09.043_bib29","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1001\/jama.2016.3964","article-title":"Efficacy of a house dust mite sublingual allergen immunotherapy tablet in adults with allergic asthma. A randomized clinical trial","volume":"315","author":"Virchow","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jaci.2016.09.043_bib30","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1939-4551-7-6","article-title":"Sublingual immunotherapy: World Allergy Organization position paper 2013 update","volume":"7","author":"Canonica","year":"2014","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jaci.2016.09.043_bibE1","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.anai.2014.11.015","article-title":"SQ house dust mite sublingually administered immunotherapy tablet (ALK) improves allergic rhinitis in patients with house dust mite allergic asthma and rhinitis symptoms","volume":"114","author":"Mosbech","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2016.09.043_bibE2","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/WOX.0b013e3181c6c379","article-title":"Sub-Lingual Immunotherapy World Allergy Organization Position Paper 2009","volume":"2","author":"Canonica","year":"2009","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jaci.2016.09.043_bibE3","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.2517-6161.1954.tb00159.x","article-title":"Some problems in interval estimation","volume":"16","author":"Fieller","year":"1954","journal-title":"J Roy Stat Soc B"},{"key":"10.1016\/j.jaci.2016.09.043_bibE4","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/pst.210","article-title":"A note on the power of Fisher's least significant difference procedure","volume":"5","author":"Meier","year":"2006","journal-title":"Pharm Stat"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674916312945?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674916312945?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:07:32Z","timestamp":1758791252000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674916312945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S0091674916312945"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2016.09.043","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of the SQ house dust mite sublingual immunotherapy tablet in Japanese adults and adolescents with house dust mite\u2013induced allergic rhinitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2016.09.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}